Selaginellatamariscina attenuates metastasis via Akt pathways in oral cancer cells

Jia-Sin Yang1, Chiao-Wen Lin, Chung-Han Hsin

  • 1Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.

Plos One
|June 27, 2013
PubMed
Abstract

Insights

Selaginella tamariscina inhibits oral cancer cell invasion by down-regulating matrix metalloproteinases (MMP-2 and MMP-9). This oriental herb may serve as an adjuvant therapy to prevent oral cancer metastasis.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Selaginella tamariscina, an oriental medicinal herb, shows therapeutic potential for various diseases.
  • Human oral squamous-cell carcinoma (OSCC) is a significant health concern.
  • Investigating the anti-cancer mechanisms of S. tamariscina is crucial for developing new treatments.

Purpose of the Study:

  • To elucidate the mechanisms by which Selaginella tamariscina inhibits the invasiveness of human oral squamous-cell carcinoma (OSCC) HSC-3 cells.
  • To evaluate the anti-metastatic potential of S. tamariscina extracts.

Main Methods:

  • Cell migration and invasion assays were performed.
  • Matrix metalloproteinases (MMP)-2 and MMP-9 activity and expression were analyzed.
  • Quantitative real-time PCR, reporter assays, and chromatin immunoprecipitation (ChIP) were utilized to assess transcriptional regulation.
  • Western blotting and kinase activity assays were employed to study signaling pathways.

Main Results:

  • Selaginella tamariscina dose-dependently inhibited HSC-3 cell migration and invasion.
  • The herb downregulated the activity and expression of MMP-2 and MMP-9 at the transcriptional level.
  • Inhibition involved decreased binding of transcription factors (CREB, AP-1, SP-1) to MMP promoters and reduced Akt activation.

Conclusions:

  • Selaginella tamariscina exhibits potent anti-metastatic properties against oral cancer cells.
  • The downregulation of MMP-2 and MMP-9 is a key mechanism of action.
  • Selaginella tamariscina shows promise as an adjuvant therapeutic agent for oral cancer prevention.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...